4//SEC Filing
Sun Yong 4
Accession 0001209191-18-046795
CIK 0001123494other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:23 PM ET
Size
11.4 KB
Accession
0001209191-18-046795
Insider Transaction Report
Form 4
Sun Yong
VP - Strategic Marketing
Transactions
- Exercise/Conversion
Common Stock
2018-08-14$4.31/sh+50,000$215,500→ 299,732 total - Tax Payment
Common Stock
2018-08-14$6.65/sh−37,588$249,960→ 262,144 total - Exercise/Conversion
Stock option (right to buy)
2018-08-14−50,000→ 0 totalExercise: $4.31Exp: 2023-11-18→ Common Stock, par value $0.01 per share (100,000 underlying)
Footnotes (5)
- [F1]Includes (a) a deferred stock award of 22,500 restricted stock units which shall vest in four equal installments on January 1, 2019, 2020, 2021 and 2022; (b) a deferred stock award of 81,847 restricted stock units which shall vest in three equal installments on January 1, 2019, 2020 and 2021; (c) a deferred stock award of 44,503 restricted stock units which shall vest in two equal installments on January 1, 2019 and 2020; (d) a deferred stock award of 4,306 restricted stock units which shall vest in full on January 1, 2019; (e) a deferred stock award of 22,500 restricted stock units with performance based vesting conditions, which shall vest in three equal installments on May 24, 2019, May 24, 2020 and May 24, 2021, contingent upon achievement of a performance condition tied to relative total shareholder return; and (f) 124,076 shares of common stock held by the Reporting Person.
- [F2]Represents the number of shares of common stock that the Reporting Person attested to the ownership thereof in accordance with the Issuer's Third Amended and Restated 2000 Stock Option and Incentive Plan, as amended, in connection with the payment of the option exercise price and taxes. With respect to each option exercise, the Issuer only delivered the net amount of the option shares (after reducing the option shares by the amount of shares subject to such attestation) to the Reporting Person and such attestation shares were not sold by the Reporting Person or delivered to the Issuer. Nevertheless, the SEC deems such exercise and related attestation to be a disposition of shares for purposes of Section 16(a) of the Securities Exchange Act of 1934.
- [F3]Includes (a) a deferred stock award of 22,500 restricted stock units which shall vest in four equal installments on January 1, 2019, 2020, 2021 and 2022; (b) a deferred stock award of 81,847 restricted stock units which shall vest in three equal installments on January 1, 2019, 2020 and 2021; (c) a deferred stock award of 44,503 restricted stock units which shall vest in two equal installments on January 1, 2019 and 2020; (d) a deferred stock award of 4,306 restricted stock units which shall vest in full on January 1, 2019; (e) a deferred stock award of 22,500 restricted stock units with performance based vesting conditions, which shall vest in three equal installments on May 24, 2019, May 24, 2020 and May 24, 2021, contingent upon achievement of a performance condition tied to relative total shareholder return; and (f) 86,488 shares of common stock held by the Reporting Person.
- [F4]Represent the exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan, as amended.
- [F5]The option vested in four equal installments on each of November 18, 2014, 2015, 2016 and 2017.
Documents
Issuer
HARVARD BIOSCIENCE INC
CIK 0001123494
Entity typeother
Related Parties
1- filerCIK 0001592266
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 4:23 PM ET
- Size
- 11.4 KB